newsfilter
← Latest News
GlobeNewswire·

Aspira Women's Health Announces Preliminary Second Quarter 2024 OvaSuite Product Volume and Highlights

Preliminary OvaWatch® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuiteSM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN, Texas, July 11, 2024